Imricor Medical Systems, Inc. (ASX: IMR) Announces Strong Q4 Results
Imricor (ASX: IMR) reports significant regulatory progress and strong revenue growth, setting a positive outlook for Q4 CY24.
Imricor (ASX: IMR) reports significant regulatory progress and strong revenue growth, setting a positive outlook for Q4 CY24.
Forbidden Foods Limited (ASX:FFF) reports significant revenue growth and operational achievements for Q2 FY25.
Nova Minerals Limited reports high-grade gold and gallium findings at its Wombat prospect, indicating growing potential in its Estelle Project.
Core Lithium Ltd (ASX: CXO) reports on its December quarterly activities, highlighting significant cash reserves, exploration success, and director appointment.
Orpheus Uranium Limited reports cash flow details for the December 2024 quarter, indicating a solid cash position for ongoing operations.
Mithril Silver and Gold Limited announces significant drilling results with impressive grades at the Copalquin District project.
Netwealth Group Limited (ASX: NWL) reports record net inflows and strong growth in FUA for the December 2024 quarter.
Insignia Financial (ASX: IFL) has received a revised proposal from Bain Capital to acquire shares at A$4.60 each, with ongoing negotiations expected.
Praemium Limited (ASX:PPS) reports a 29% increase in FUA to $62.1 billion, highlighting strong growth metrics and inflows for Q2 FY2025.
Firebrick Pharma Ltd reports significant operational and financial updates, marking progress in Singapore sales of Nasodine during the December quarter.